Top Insights
Stock in Tylenol’s parent company rallies after Trump’s unproven claims
Tylenol’s parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
Related Articles
Mamdani’s Stand on Genocide is More Important than the Dynamics of Arresting Netanyahu
NEW YORK, September 23 (IPS) – No leader responsible for mass atrocities...
Live Updates: Trump Addresses U.N. General Assembly
Trump’s speech comes as the United States has withdrawn funding and support...
Peter Mutharika Set to Return to Power in Malawi
Peter Mutharika, an 85-year-old Yale-educated law professor, looked on course to defeat...
Palestinian, Jordan authorities say Israel to indefinitely close West Bank crossing
Israel will indefinitely shut the only crossing between the West Bank and...
Leave a comment